Connect
← Return to What is the current position on the length of hormone treatment?
Discussion
What is the current position on the length of hormone treatment?
Prostate Cancer | Last Active: Jan 7 9:31am | Replies (46)Comment receiving replies
For those that had treatment that follows the ARSENS trial (i.e., ADT, Darolutamide, and 6 Cycles of Docetaxel). The newest data released by the ARSENS trial.
Overall Survival - Still Not Reached (NR)
Time to Castrate Resistance - Still Not Reached (NR)
It has been 5+ years now. This is promising news.
Replies to "For those that had treatment that follows the ARSENS trial (i.e., ADT, Darolutamide, and 6 Cycles..."
Connect
Where did you see that? My MO at JH was essentially following the ARASENS trial but he believes there is no supporting data that 6 cycles of Docetaxel is any better than 4. My Darolutamide was discontinued after the chemo (PSA was undetectable). He strongly suggested pelvic radiation as I had a positive node on PSMA PET prior to beginning the triple therapy. My Lupron was discontinued after year with PSA still undetectable.
Was this similar to your treatment? I don't believe there is a set in stone protocol for the triple therapy at this time and trials are underway to assess the best exact protocol.